ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Ryaltris, spray nasal, suspension:NOBEL Pharma Schweiz AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Composition

Principes actifs
Mometasoni-17 furoas ut Mometasoni-17 furoas monohydricus, Olopatadinum ut Olopatadini hydrochloridum.
Excipients
Cellulosum microcristallinum (E460), Dinatrii phosphas heptahydricus (E339), Carmellosum natricum (E466), Natrii chloridum, Benzalkonii chloridum (0.20 mg), Glycerolum (E422), Dinatrii edetas, Polysorbatum 80 (E433), Acidum hydrochloricum concentratum (E507), Natrii hydroxidum (E524), Aqua ad iniectabile ad suspensionem pro 1 g.

2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home